查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1593743

全球非处方镇痛药市场评估：按药物类型、给药途径、分销管道、地区、机会和预测（2017-2031）

Over-the-Counter (OTC) Analgesics Market Assessment, By Drug Type, By Route of Administration, By Distribution Channel, By Region, Opportunities and Forecast, 2017-2031F
出版日期: | 出版商: Market Xcel - Markets and Data | 英文 236 Pages | 商品交期: 3-5个工作天内

价格

全球非处方止痛药市场规模预计将从 2023 年的 300.4 亿美元增至 2031 年的 419.1 亿美元，预计 2024-2031 年期间复合年增长率为 4.25%。市场扩张可归因于消费者对疼痛管理意识的提高、获得非处方药的便利性以及自我药疗的日益普及。此外，非处方止痛药的高成本效率、老年人口的增加以及各种疾病盛行率的增加对全球非处方止痛药市场的扩张产生了积极影响。

此外，主要製药公司加大力度广泛采用止痛药也为市场创造了利润丰厚的成长机会。 2023 年3 月，消费者自我照护产品领域的领先公司之一Perrigo Company plc 宣布其布洛芬和对乙酰氨基酚片剂的简略新药申请(ANDA) 已获得美国食品和药物管理局(FDA) 的批准。这种从处方药到非处方药的批准增强了公司的开发和监管能力，使其能够快速发展业务并满足消费者需求。

此外，对自我药疗的日益偏好是全球非处方止痛药市场的关键驱动因素之一。由于其便利性和生活方式的复杂性，越来越多的患者选择自我药疗来有效管理轻微症状。这种增长推动了对非处方止痛药的需求，因为它们提供了一种廉价且省时的方法来控制疼痛，而无需医疗专业人员。取得非处方止痛药的便利性和网路药局的快速扩张也推动了全球非处方止痛药的需求。尤其是线上药局，预计将在非处方止痛药的使用中发挥重要作用，因为它们允许消费者比较价格并提供详细的产品说明，帮助他们做出明智的决定。

本报告研究和分析了全球非处方止痛药市场，提供市场规模和预测、市场动态以及主要参与者的状况。

目录

第一章专案范围与定义

第二章研究方法

第 3 章执行摘要

第四章全球非处方止痛药市场展望（2017-2031）

  • 市场规模分析与预测
    • 金额
  • 市占率分析与预测
    • 依药物类型
    • 依给药途径
    • 按分销管道
    • 按地区
    • 市占率分析：按公司划分（金额）（前 5 名公司及其他 - 2023 年）
  • 市场地图分析（2023 年）
    • 依药物类型
    • 依给药途径
    • 按分销管道
    • 按地区

第五章北美非处方止痛药市场展望（2017-2031）

  • 市场规模分析与预测
    • 金额
  • 市占率分析与预测
    • 依药物类型
    • 依给药途径
    • 按分销管道
    • 分享：依国家/地区
  • 每个国家市场的评估
    • 美国止痛药市场前景（2017-2031）
    • 加拿大
    • 墨西哥

第六章欧洲非处方止痛药市场展望（2017-2031）

  • 德国
  • 法国
  • 义大利
  • 英国
  • 俄罗斯
  • 荷兰
  • 西班牙
  • 波兰

第七章亚太非处方止痛药市场前景（2017-2031）

  • 印度
  • 中国
  • 日本
  • 澳大利亚
  • 越南
  • 韩国
  • 印尼
  • 菲律宾

第8章南美OTC止痛药市场展望（2017-2031）

  • 巴西
  • 阿根廷

第9章中东及非洲非处方止痛药市场前景（2017-2031）

  • 沙乌地阿拉伯
  • 阿拉伯联合大公国
  • 南非
  • 以色列

第10章供需分析

第十一章进出口分析

第十二章价值链分析

第 13 章波特五力分析

第14章PESTLE分析

第十五章价格分析

第 16 章市场动态

  • 市场驱动因素
  • 市场课题

第十七章市场趋势与发展

第 18 章监理架构与创新

  • 临床试验
  • 监理机关的核准

第十九章专利状况

第 20 章个案研究

第21章竞争态势

  • 前 5 名市场领导者的竞争矩阵
  • 前 5 名的公司的 SWOT 分析
  • 前10名主要企业状况
    • Novartis AG
    • Boehringer Ingelheim International GmbH
    • Endo, Inc.
    • Bayer AG
    • Johnson & Johnson Services, Inc.
    • Groupe Sanofi
    • Teva Pharmaceutical Industries Ltd.
    • Haleon plc
    • Viatris Inc.
    • Reckitt Benckiser Group PLC

第22章策略建议

第23章关于我们公司，免责声明

Product Code: MX12255

Global over-the-counter (OTC) analgesics market is projected to witness a CAGR of 4.25% during the forecast period 2024-2031, growing from USD 30.04 billion in 2023 to USD 41.91 billion in 2031. The expansion of the market can be attributed to growing consumer awareness of pain management, easy accessibility to OTC drugs, and the increasing popularity of self-medication. Additionally, the cost-efficient nature of OTC analgesics, the expansion of the geriatric population, and the growing prevalence of different diseases positively influence the expansion of the global OTC analgesics market.

Furthermore, the rising efforts by the leading pharmaceutical companies to propel the availability of analgesics are also providing lucrative growth opportunities to the market. In March 2023, Perrigo Company plc, one of the leading providers of consumer self-care products, announced that they had been approved by the US Food and Drug Administration (FDA) for their abbreviated new drug application (ANDA) for Ibuprofen and Acetaminophen tablets. This prescription-to-OTC approval strengthens the company's development and regulatory capabilities, allowing it to grow its business at a rapid rate and meet consumer requirements.

Additionally, the growing preference for self-medication is one of the major drivers of the global Over-the-Counter (OTC) analgesics market. Patients are increasingly opting for self-medication to effectively manage minor health conditions due to its convenient nature and growing lifestyle complexities. This increase is boosting the demand for OTC analgesics as they allow individuals to manage their pain in a cost and time-efficient manner without requiring a visit to a healthcare professional. The easy accessibility to OTC analgesics coupled with the rapid expansion of online pharmacies also propels the global demand for OTC analgesics. Online pharmacies, in particular, are expected to play a significant role in boosting the reach of OTC analgesics as they allow consumers to compare prices and provide detailed product descriptions, aiding them in making informed decisions.

Expansion of Geriatric Population Boosts Market Demand

The rapid expansion of the geriatric population is one of the major factors boosting the global OTC analgesics market size, as the older population is more prone to chronic pain and prefers self-medication and cost-effective solutions. As per the World Health Organization (WHO) estimates, by 2030, 1 in 6 individuals across the globe will be sixty or older, propelling the demand for OTC analgesics. Persistent musculoskeletal pain is highly prevalent among the older population, and multisite pain contributes to significant disability among them. The older population is also more likely to experience chronic conditions that cause persistent pain, including osteoporosis, back pain, and arthritis, among others. Additionally, the natural wear and tear of muscles, joints, and bones coupled with age-related diseases results in higher incidences of pain among the elderly, bolstering the requirement for OTC analgesics. Furthermore, the older population prefers self-medication and relies on OTC analgesics for managing mild to moderate pain as they are readily available and do not require a prescription. This appeals to older individuals as they often require OTC solutions to address their immediate needs and discomfort and may not want to visit a physician frequently.

Rising Cases of Chronic Pain Causing Conditions Supports Market Expansion

Chronic pain is often caused by health conditions that last for a long period and can cause a hindrance for individuals to complete their daily tasks and function normally. Thus, individuals living with such conditions often rely on OTC analgesics for managing pain. The American Migraine Foundation (AMF) estimates that approximately 148 million individuals across the globe are suffering from chronic migraine. Other chronic conditions responsible for causing long-term pain include fibromyalgia, arthritis, and osteoporosis, among others. Additionally, prolonged periods of desk work, a sedentary lifestyle, and poor posture are propelling the occurrence of lifestyle-related conditions that are increasing the incidences of conditions, including musculoskeletal disorders, neck pain, and back pain, increasing the requirement for OTC analgesics. Furthermore, the rising cases of autoimmune diseases, including multiple sclerosis, lupus, and rheumatoid arthritis, which are known to cause inflammation and chronic pain, are also expected to provide lucrative growth opportunities to the market. According to the estimates of the WHO, over 1.8 million individuals across the globe have multiple sclerosis. Individuals suffering from such conditions often rely on OTC analgesics for the management of pain, thus bolstering the market's demand.

Topical Analgesics Witness Significant Growth

The increasing popularity of topical analgesics is supported by their minimal systemic absorption and localized action. Sprays, creams, gels, and patches are preferred by individuals looking for targeted pain relief and are often preferred by those suffering from sports injuries and musculoskeletal disorders, among others. Also, novel pharma company launches are supporting the segment's expansion. In September 2024, Mankind Pharma Ltd. launched Nimulid Strong, a spray and a gel formulation for addressing neck pain. This condition has a significant impact on the overall functioning of the body. With this launch, the company has entered the topical analgesics market. The product will be distributed across modern trade outlets and pharmacies across India. Such launches are expected to aid pharmaceutical companies in expanding their consumer healthcare portfolio. The introduction of novel and innovative products that redefine the topical analgesics segment is also expected to bolster the global over-the-counter (OTC) analgesics market growth. In July 2024, Wellness Formulations, LLC announced the launch of their ralli Rapid Pain Relief, which combines advanced features that consumers have been anticipating with the powerful pain relief of menthol. Ralli stands out because of its unique blend of skin conditioners and penetration enhancers that deliver effective pain relief without leaving a greasy residue that can usually be found.

North America Holds Major Market Share

The growth of North America over-the-counter analgesics market can be attributed to the rising incidences of sports-related injuries due to the growing popularity of sports activities, increasing cases of musculoskeletal diseases, well-established healthcare infrastructure, and high consumer awareness. As per the estimates of Johns Hopkins Medicine, in the United States, approximately 30 million teens and children participate in some sort of organized sports every year, and over 3.5 million injuries occur each year, thus propelling the requirement for OTC analgesics for effective pain management.

Furthermore, in the United States, the requirement for OTC analgesics is also increasing due to the rising prevalence of conditions such as back pain, arthritis, and migraines. According to the estimates of the AMF, over 37 million men, women, and children in the United States are suffering from migraine. Additionally, the easy availability of OTC analgesics through online and retail pharmacies and supermarkets supports the market's growth in North America. Meanwhile, the strong presence of leading pharmaceutical companies and market players is ensuring the availability of novel drugs in the region, positively influencing the expansion of the over-the-counter (OTC) analgesics market.

Future Market Scenario (2024-2031F)

As per the global over-the-counter analgesics market analysis, the market's demand is expected to witness significant growth in the coming years due to the rising cases of pain prevalent conditions and rapid growth of the geriatric population. The WHO estimates that by 2050, the global population accounting for individuals aged sixty and above will be 2.1 billion. This growth is expected to bolster the requirement for OTC analgesics as the older population is more prone to pains and aches. Additionally, the development of novel drug formulations, including fast-acting and sustained-release tablets, is expected to play a crucial role in the market's expansion. Moreover, the growing popularity of online pharmacies and e-commerce will provide new growth opportunities for drug manufacturers and increase consumer accessibility to a wide range of products.

Meanwhile, the market is expected to witness a shift towards organic and natural pain relief alternatives due to the increasing health consciousness among the general population and rising demand for alternatives to chemical-based medications. Key market players are also continuously investing in research and development activities to produce innovative, effective, and safer analgesics to gain a competitive edge.

Key Players Landscape and Outlook

The key players of the market are focused on selling and purchasing OTC units to utilize their resources on other products and expand their product portfolios, respectively. In October 2024, Groupe Sanofi confirmed their plans to sell a controlling stake in their OTC unit for approximately USD 17 billion (€16 billion).

Due to the rising demand for OTC analgesics, among other pharmaceutical products, market players are witnessing significant revenue growth. In August 2024, Haleon plc launched a share buyback program of up to USD 237 million (£185 million) as the company reported strong organic operating profit growth, substantial organic revenue growth, and a good first half.

Table of Contents

1. Project Scope and Definitions

2. Research Methodology

3. Executive Summary

4. Global Over-the-Counter (OTC) Analgesics Market Outlook, 2017-2031F

  • 4.1. Market Size Analysis & Forecast
    • 4.1.1. By Value
  • 4.2. Market Share Analysis & Forecast
    • 4.2.1. By Drug Type
      • 4.2.1.1. Acetaminophen
      • 4.2.1.2. Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
      • 4.2.1.3. Salicylates
      • 4.2.1.4. Others
    • 4.2.2. By Route of Administration
      • 4.2.2.1. Oral
      • 4.2.2.2. Parenteral
      • 4.2.2.3. Topical
    • 4.2.3. By Distribution Channel
      • 4.2.3.1. Hospital Pharmacies
      • 4.2.3.2. Retail Pharmacies
      • 4.2.3.3. Online Pharmacies
      • 4.2.3.4. Others
    • 4.2.4. By Region
      • 4.2.4.1. North America
      • 4.2.4.2. Europe
      • 4.2.4.3. Asia-Pacific
      • 4.2.4.4. South America
      • 4.2.4.5. Middle East and Africa
    • 4.2.5. By Company Market Share Analysis (Top 5 Companies and Others - By Value, 2023)
  • 4.3. Market Map Analysis, 2023
    • 4.3.1. By Drug Type
    • 4.3.2. By Route of Administration
    • 4.3.3. By Distribution Channel
    • 4.3.4. By Region

5. North America Over-the-Counter (OTC) Analgesics Market Outlook, 2017-2031F*

  • 5.1. Market Size Analysis & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share Analysis & Forecast
    • 5.2.1. By Drug Type
      • 5.2.1.1. Acetaminophen
      • 5.2.1.2. Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
      • 5.2.1.3. Salicylates
      • 5.2.1.4. Others
    • 5.2.2. By Route of Administration
      • 5.2.2.1. Oral
      • 5.2.2.2. Parenteral
      • 5.2.2.3. Topical
    • 5.2.3. By Distribution Channel
      • 5.2.3.1. Hospital Pharmacies
      • 5.2.3.2. Retail Pharmacies
      • 5.2.3.3. Online Pharmacies
      • 5.2.3.4. Others
    • 5.2.4. By Country Share
      • 5.2.4.1. United States
      • 5.2.4.2. Canada
      • 5.2.4.3. Mexico
  • 5.3. Country Market Assessment
    • 5.3.1. United States Over-the-Counter (OTC) Analgesics Market Outlook, 2017-2031F*
      • 5.3.1.1. Market Size Analysis & Forecast
        • 5.3.1.1.1. By Value
      • 5.3.1.2. Market Share Analysis & Forecast
        • 5.3.1.2.1. By Drug Type
          • 5.3.1.2.1.1. Acetaminophen
          • 5.3.1.2.1.2. Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
          • 5.3.1.2.1.3. Salicylates
          • 5.3.1.2.1.4. Others
        • 5.3.1.2.2. By Route of Administration
          • 5.3.1.2.2.1. Oral
          • 5.3.1.2.2.2. Parenteral
          • 5.3.1.2.2.3. Topical
        • 5.3.1.2.3. By Distribution Channel
          • 5.3.1.2.3.1. Hospital Pharmacies
          • 5.3.1.2.3.2. Retail Pharmacies
          • 5.3.1.2.3.3. Online Pharmacies
          • 5.3.1.2.3.4. Others
    • 5.3.2. Canada
    • 5.3.3. Mexico

All segments will be provided for all regions and countries covered

6. Europe Over-the-Counter (OTC) Analgesics Market Outlook, 2017-2031F

  • 6.1. Germany
  • 6.2. France
  • 6.3. Italy
  • 6.4. United Kingdom
  • 6.5. Russia
  • 6.6. Netherlands
  • 6.7. Spain
  • 6.8. Poland

7. Asia-Pacific Over-the-Counter (OTC) Analgesics Market Outlook, 2017-2031F

  • 7.1. India
  • 7.2. China
  • 7.3. Japan
  • 7.4. Australia
  • 7.5. Vietnam
  • 7.6. South Korea
  • 7.7. Indonesia
  • 7.8. Philippines

8. South America Over-the-Counter (OTC) Analgesics Market Outlook, 2017-2031F

  • 8.1. Brazil
  • 8.2. Argentina

9. Middle East and Africa Over-the-Counter (OTC) Analgesics Market Outlook, 2017-2031F

  • 9.1. Saudi Arabia
  • 9.2. UAE
  • 9.3. South Africa
  • 9.4. Israel

10. Demand Supply Analysis

11. Import and Export Analysis

12. Value Chain Analysis

13. Porter's Five Forces Analysis

14. PESTLE Analysis

15. Pricing Analysis

16. Market Dynamics

  • 16.1. Market Drivers
  • 16.2. Market Challenges

17. Market Trends and Developments

18. Regulatory Framework and Innovation

  • 18.1. Clinical Trials
  • 18.2. Regulatory Approvals

19. Patent Landscape

20. Case Studies

21. Competitive Landscape

  • 21.1. Competition Matrix of Top 5 Market Leaders
  • 21.2. SWOT Analysis for Top 5 Players
  • 21.3. Key Players Landscape for Top 10 Market Players
    • 21.3.1. Novartis AG
      • 21.3.1.1. Company Details
      • 21.3.1.2. Key Management Personnel
      • 21.3.1.3. Products and Services
      • 21.3.1.4. Financials (As Reported)
      • 21.3.1.5. Key Market Focus and Geographical Presence
      • 21.3.1.6. Recent Developments/Collaborations/Partnerships/Mergers and Acquisitions
    • 21.3.2. Boehringer Ingelheim International GmbH
    • 21.3.3. Endo, Inc.
    • 21.3.4. Bayer AG
    • 21.3.5. Johnson & Johnson Services, Inc.
    • 21.3.6. Groupe Sanofi
    • 21.3.7. Teva Pharmaceutical Industries Ltd.
    • 21.3.8. Haleon plc
    • 21.3.9. Viatris Inc.
    • 21.3.10. Reckitt Benckiser Group PLC

Companies mentioned above DO NOT hold any order as per market share and can be changed as per information available during research work.

22. Strategic Recommendations

23. About Us and Disclaimer

List of Tables

  • Table 1. Pricing Analysis of Products from Key Players
  • Table 2. Competition Matrix of Top 5 Market Leaders
  • Table 3. Mergers & Acquisitions/ Joint Ventures (If Applicable)
  • Table 4. About Us - Regions and Countries Where We Have Executed Client Projects

List of Figures

  • Figure 1. Global Over-the-Counter (OTC) Analgesics Market, By Value, In USD Billion, 2017-2031F
  • Figure 2. Global Over-the-Counter (OTC) Analgesics Market Share (%), By Drug Type, 2017-2031F
  • Figure 3. Global Over-the-Counter (OTC) Analgesics Market Share (%), By Route of Administration, 2017-2031F
  • Figure 4. Global Over-the-Counter (OTC) Analgesics Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 5. Global Over-the-Counter (OTC) Analgesics Market Share (%), By Region, 2017-2031F
  • Figure 6. North America Over-the-Counter (OTC) Analgesics Market, By Value, In USD Billion, 2017-2031F
  • Figure 7. North America Over-the-Counter (OTC) Analgesics Market Share (%), By Drug Type, 2017-2031F
  • Figure 8. North America Over-the-Counter (OTC) Analgesics Market Share (%), By Route of Administration, 2017-2031F
  • Figure 9. North America Over-the-Counter (OTC) Analgesics Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 10. North America Over-the-Counter (OTC) Analgesics Market Share (%), By Country, 2017-2031F
  • Figure 11. United States Over-the-Counter (OTC) Analgesics Market, By Value, In USD Billion, 2017-2031F
  • Figure 12. United States Over-the-Counter (OTC) Analgesics Market Share (%), By Drug Type, 2017-2031F
  • Figure 13. United States Over-the-Counter (OTC) Analgesics Market Share (%), By Route of Administration, 2017-2031F
  • Figure 14. United States Over-the-Counter (OTC) Analgesics Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 15. Canada Over-the-Counter (OTC) Analgesics Market, By Value, In USD Billion, 2017-2031F
  • Figure 16. Canada Over-the-Counter (OTC) Analgesics Market Share (%), By Drug Type, 2017-2031F
  • Figure 17. Canada Over-the-Counter (OTC) Analgesics Market Share (%), By Route of Administration, 2017-2031F
  • Figure 18. Canada Over-the-Counter (OTC) Analgesics Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 19. Mexico Over-the-Counter (OTC) Analgesics Market, By Value, In USD Billion, 2017-2031F
  • Figure 20. Mexico Over-the-Counter (OTC) Analgesics Market Share (%), By Drug Type, 2017-2031F
  • Figure 21. Mexico Over-the-Counter (OTC) Analgesics Market Share (%), By Route of Administration, 2017-2031F
  • Figure 22. Mexico Over-the-Counter (OTC) Analgesics Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 23. Europe Over-the-Counter (OTC) Analgesics Market, By Value, In USD Billion, 2017-2031F
  • Figure 24. Europe Over-the-Counter (OTC) Analgesics Market Share (%), By Drug Type, 2017-2031F
  • Figure 25. Europe Over-the-Counter (OTC) Analgesics Market Share (%), By Route of Administration, 2017-2031F
  • Figure 26. Europe Over-the-Counter (OTC) Analgesics Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 27. Europe Over-the-Counter (OTC) Analgesics Market Share (%), By Country, 2017-2031F
  • Figure 28. Germany Over-the-Counter (OTC) Analgesics Market, By Value, In USD Billion, 2017-2031F
  • Figure 29. Germany Over-the-Counter (OTC) Analgesics Market Share (%), By Drug Type, 2017-2031F
  • Figure 30. Germany Over-the-Counter (OTC) Analgesics Market Share (%), By Route of Administration, 2017-2031F
  • Figure 31. Germany Over-the-Counter (OTC) Analgesics Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 32. France Over-the-Counter (OTC) Analgesics Market, By Value, In USD Billion, 2017-2031F
  • Figure 33. France Over-the-Counter (OTC) Analgesics Market Share (%), By Drug Type, 2017-2031F
  • Figure 34. France Over-the-Counter (OTC) Analgesics Market Share (%), By Route of Administration, 2017-2031F
  • Figure 35. France Over-the-Counter (OTC) Analgesics Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 36. Italy Over-the-Counter (OTC) Analgesics Market, By Value, In USD Billion, 2017-2031F
  • Figure 37. Italy Over-the-Counter (OTC) Analgesics Market Share (%), By Drug Type, 2017-2031F
  • Figure 38. Italy Over-the-Counter (OTC) Analgesics Market Share (%), By Route of Administration, 2017-2031F
  • Figure 39. Italy Over-the-Counter (OTC) Analgesics Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 40. United Kingdom Over-the-Counter (OTC) Analgesics Market, By Value, In USD Billion, 2017-2031F
  • Figure 41. United Kingdom Over-the-Counter (OTC) Analgesics Market Share (%), By Drug Type, 2017-2031F
  • Figure 42. United Kingdom Over-the-Counter (OTC) Analgesics Market Share (%), By Route of Administration, 2017-2031F
  • Figure 43. United Kingdom Over-the-Counter (OTC) Analgesics Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 44. Russia Over-the-Counter (OTC) Analgesics Market, By Value, In USD Billion, 2017-2031F
  • Figure 45. Russia Over-the-Counter (OTC) Analgesics Market Share (%), By Drug Type, 2017-2031F
  • Figure 46. Russia Over-the-Counter (OTC) Analgesics Market Share (%), By Route of Administration, 2017-2031F
  • Figure 47. Russia Over-the-Counter (OTC) Analgesics Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 48. Netherlands Over-the-Counter (OTC) Analgesics Market, By Value, In USD Billion, 2017-2031F
  • Figure 49. Netherlands Over-the-Counter (OTC) Analgesics Market Share (%), By Drug Type, 2017-2031F
  • Figure 50. Netherlands Over-the-Counter (OTC) Analgesics Market Share (%), By Route of Administration, 2017-2031F
  • Figure 51. Netherlands Over-the-Counter (OTC) Analgesics Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 52. Spain Over-the-Counter (OTC) Analgesics Market, By Value, In USD Billion, 2017-2031F
  • Figure 53. Spain Over-the-Counter (OTC) Analgesics Market Share (%), By Drug Type, 2017-2031F
  • Figure 54. Spain Over-the-Counter (OTC) Analgesics Market Share (%), By Route of Administration, 2017-2031F
  • Figure 55. Spain Over-the-Counter (OTC) Analgesics Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 56. Turkey Over-the-Counter (OTC) Analgesics Market, By Value, In USD Billion, 2017-2031F
  • Figure 57. Turkey Over-the-Counter (OTC) Analgesics Market Share (%), By Drug Type, 2017-2031F
  • Figure 58. Turkey Over-the-Counter (OTC) Analgesics Market Share (%), By Route of Administration, 2017-2031F
  • Figure 59. Turkey Over-the-Counter (OTC) Analgesics Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 60. Poland Over-the-Counter (OTC) Analgesics Market, By Value, In USD Billion, 2017-2031F
  • Figure 61. Poland Over-the-Counter (OTC) Analgesics Market Share (%), By Drug Type, 2017-2031F
  • Figure 62. Poland Over-the-Counter (OTC) Analgesics Market Share (%), By Route of Administration, 2017-2031F
  • Figure 63. Poland Over-the-Counter (OTC) Analgesics Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 64. South America Over-the-Counter (OTC) Analgesics Market, By Value, In USD Billion, 2017-2031F
  • Figure 65. South America Over-the-Counter (OTC) Analgesics Market Share (%), By Drug Type, 2017-2031F
  • Figure 66. South America Over-the-Counter (OTC) Analgesics Market Share (%), By Route of Administration, 2017-2031F
  • Figure 67. South America Over-the-Counter (OTC) Analgesics Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 68. South America Over-the-Counter (OTC) Analgesics Market Share (%), By Country, 2017-2031F
  • Figure 69. Brazil Over-the-Counter (OTC) Analgesics Market, By Value, In USD Billion, 2017-2031F
  • Figure 70. Brazil Over-the-Counter (OTC) Analgesics Market Share (%), By Drug Type, 2017-2031F
  • Figure 71. Brazil Over-the-Counter (OTC) Analgesics Market Share (%), By Route of Administration, 2017-2031F
  • Figure 72. Brazil Over-the-Counter (OTC) Analgesics Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 73. Argentina Over-the-Counter (OTC) Analgesics Market, By Value, In USD Billion, 2017-2031F
  • Figure 74. Argentina Over-the-Counter (OTC) Analgesics Market Share (%), By Drug Type, 2017-2031F
  • Figure 75. Argentina Over-the-Counter (OTC) Analgesics Market Share (%), By Route of Administration, 2017-2031F
  • Figure 76. Argentina Over-the-Counter (OTC) Analgesics Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 77. Asia-Pacific Over-the-Counter (OTC) Analgesics Market, By Value, In USD Billion, 2017-2031F
  • Figure 78. Asia-Pacific Over-the-Counter (OTC) Analgesics Market Share (%), By Drug Type, 2017-2031F
  • Figure 79. Asia-Pacific Over-the-Counter (OTC) Analgesics Market Share (%), By Route of Administration, 2017-2031F
  • Figure 80. Asia-Pacific Over-the-Counter (OTC) Analgesics Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 81. Asia-Pacific Over-the-Counter (OTC) Analgesics Market Share (%), By Country, 2017-2031F
  • Figure 82. India Over-the-Counter (OTC) Analgesics Market, By Value, In USD Billion, 2017-2031F
  • Figure 83. India Over-the-Counter (OTC) Analgesics Market Share (%), By Drug Type, 2017-2031F
  • Figure 84. India Over-the-Counter (OTC) Analgesics Market Share (%), By Route of Administration, 2017-2031F
  • Figure 85. India Over-the-Counter (OTC) Analgesics Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 86. China Over-the-Counter (OTC) Analgesics Market, By Value, In USD Billion, 2017-2031F
  • Figure 87. China Over-the-Counter (OTC) Analgesics Market Share (%), By Drug Type, 2017-2031F
  • Figure 88. China Over-the-Counter (OTC) Analgesics Market Share (%), By Route of Administration, 2017-2031F
  • Figure 89. China Over-the-Counter (OTC) Analgesics Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 90. Japan Over-the-Counter (OTC) Analgesics Market, By Value, In USD Billion, 2017-2031F
  • Figure 91. Japan Over-the-Counter (OTC) Analgesics Market Share (%), By Drug Type, 2017-2031F
  • Figure 92. Japan Over-the-Counter (OTC) Analgesics Market Share (%), By Route of Administration, 2017-2031F
  • Figure 93. Japan Over-the-Counter (OTC) Analgesics Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 94. Australia Over-the-Counter (OTC) Analgesics Market, By Value, In USD Billion, 2017-2031F
  • Figure 95. Australia Over-the-Counter (OTC) Analgesics Market Share (%), By Drug Type, 2017-2031F
  • Figure 96. Australia Over-the-Counter (OTC) Analgesics Market Share (%), By Route of Administration, 2017-2031F
  • Figure 97. Australia Over-the-Counter (OTC) Analgesics Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 98. Vietnam Over-the-Counter (OTC) Analgesics Market, By Value, In USD Billion, 2017-2031F
  • Figure 99. Vietnam Over-the-Counter (OTC) Analgesics Market Share (%), By Drug Type, 2017-2031F
  • Figure 100. Vietnam Over-the-Counter (OTC) Analgesics Market Share (%), By Route of Administration, 2017-2031F
  • Figure 101. Vietnam Over-the-Counter (OTC) Analgesics Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 102. South Korea Over-the-Counter (OTC) Analgesics Market, By Value, In USD Billion, 2017-2031F
  • Figure 103. South Korea Over-the-Counter (OTC) Analgesics Market Share (%), By Drug Type, 2017-2031F
  • Figure 104. South Korea Over-the-Counter (OTC) Analgesics Market Share (%), By Route of Administration, 2017-2031F
  • Figure 105. South Korea Over-the-Counter (OTC) Analgesics Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 106. Indonesia Over-the-Counter (OTC) Analgesics Market, By Value, In USD Billion, 2017-2031F
  • Figure 107. Indonesia Over-the-Counter (OTC) Analgesics Market Share (%), By Drug Type, 2017-2031F
  • Figure 108. Indonesia Over-the-Counter (OTC) Analgesics Market Share (%), By Route of Administration, 2017-2031F
  • Figure 109. Indonesia Over-the-Counter (OTC) Analgesics Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 110. Philippines Over-the-Counter (OTC) Analgesics Market, By Value, In USD Billion, 2017-2031F
  • Figure 111. Philippines Over-the-Counter (OTC) Analgesics Market Share (%), By Drug Type, 2017-2031F
  • Figure 112. Philippines Over-the-Counter (OTC) Analgesics Market Share (%), By Route of Administration, 2017-2031F
  • Figure 113. Philippines Over-the-Counter (OTC) Analgesics Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 114. Middle East & Africa Over-the-Counter (OTC) Analgesics Market, By Value, In USD Billion, 2017-2031F
  • Figure 115. Middle East & Africa Over-the-Counter (OTC) Analgesics Market Share (%), By Drug Type, 2017-2031F
  • Figure 116. Middle East & Africa Over-the-Counter (OTC) Analgesics Market Share (%), By Route of Administration, 2017-2031F
  • Figure 117. Middle East & Africa Over-the-Counter (OTC) Analgesics Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 118. Middle East & Africa Over-the-Counter (OTC) Analgesics Market Share (%), By Country, 2017-2031F
  • Figure 119. Saudi Arabia Over-the-Counter (OTC) Analgesics Market, By Value, In USD Billion, 2017-2031F
  • Figure 120. Saudi Arabia Over-the-Counter (OTC) Analgesics Market Share (%), By Drug Type, 2017-2031F
  • Figure 121. Saudi Arabia Over-the-Counter (OTC) Analgesics Market Share (%), By Route of Administration, 2017-2031F
  • Figure 122. Saudi Arabia Over-the-Counter (OTC) Analgesics Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 123. UAE Over-the-Counter (OTC) Analgesics Market, By Value, In USD Billion, 2017-2031F
  • Figure 124. UAE Over-the-Counter (OTC) Analgesics Market Share (%), By Drug Type, 2017-2031F
  • Figure 125. UAE Over-the-Counter (OTC) Analgesics Market Share (%), By Route of Administration, 2017-2031F
  • Figure 126. UAE Over-the-Counter (OTC) Analgesics Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 127. South Africa Over-the-Counter (OTC) Analgesics Market, By Value, In USD Billion, 2017-2031F
  • Figure 128. South Africa Over-the-Counter (OTC) Analgesics Market Share (%), By Drug Type, 2017-2031F
  • Figure 129. South Africa Over-the-Counter (OTC) Analgesics Market Share (%), By Route of Administration, 2017-2031F
  • Figure 130. South Africa Over-the-Counter (OTC) Analgesics Market Share (%), By Distribution Channel, 2017-2031F
  • Figure 131. By Drug Type Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 132. By Route of Administration Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 133. By Distribution Channel Map-Market Size (USD Billion) & Growth Rate (%), 2023
  • Figure 134. By Region Map-Market Size (USD Billion) & Growth Rate (%), 2023